Evidence map›Paper›PMID 36430689›Full record

ArticleInternational journal of molecular sciences2022

Association of Irisin/FNDC5 with ERRα and PGC-1α Expression in NSCLC.

Katarzyna Nowińska, Karolina Jabłońska, Urszula Ciesielska, Aleksandra Piotrowska, Katarzyna Haczkiewicz-Leśniak, Konrad Pawełczyk, Marzenna Podhorska-Okołów, Piotr Dzięgiel

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05876728 unknown statusnot on this mapstarted 2023, after this paper: background citation

Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer

TypeobservationalSponsorSohag UniversityRan2023 to 2024Enrolled100ConditionsBreast CancerArmsGenotyping
NCT06023745 unknown statusnot on this mapstarted 2023, after this paper: background citation

Study IL- 35 Level and Fibronectin Type Ⅲ Domain Containing Protein 5 \ Irsin (FNDC5 rs3480) Gene Variations in Chronic Hepatitis B.

TypeobservationalSponsorSohag UniversityRan2023 to 2023Enrolled80ConditionsHepatitis B, ChronicArmsgenotyping
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer.International journal of molecular sciences · 2023
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Katarzyna NowińskaDivision of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0001-8316-8893
Karolina JabłońskaDivision of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Urszula CiesielskaDivision of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Aleksandra PiotrowskaDivision of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0003-4093-7386
Katarzyna Haczkiewicz-LeśniakDivision of Ultrastructural Research, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Konrad PawełczykLower Silesian Centre of Oncology, Pulmonology and Haematology, 53-439 Wroclaw, Poland.ORCID 0000-0001-8275-7266
Marzenna Podhorska-OkołówDivision of Ultrastructural Research, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Piotr DzięgielDivision of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Wroclaw Medical University · PLLublin Oncology Center · PL

Funding

Wroclaw Medical University STM.A352.20.003
6 · The paper itself

Abstract

The rapid growth and division of cancer cells are associated with mitochondrial biogenesis or switching to glycolysis. ERRα, PGC-1α and irisin/FNDC5 are some of the proteins that can influence these processes. The aim of this study was to determine the correlation of these proteins in non-small cell lung cancer (NSCLC) and to investigate their association with clinicopathological parameters. Immunohistochemistry reactions were performed on tissue microarrays (860 NSCLC, 140 non-malignant lung tissue). The normal fibroblast cell line (IMR-90) and lung cancer cell lines (NCI-H1703 and NCI-H522) were used as co-cultures. The mRNA levels of

Indexed as

Carcinoma, Non-Small-Cell LungFibronectinsERRalpha Estrogen-Related ReceptorHumansLung NeoplasmsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaReceptors, EstrogenRNA, MessengerTranscription FactorsERRalpha Estrogen-Related ReceptorFibronectinsFNDC5 protein, humanPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humanReceptors, EstrogenRNA, MessengerTranscription FactorsERRαESRRAFNDC5irisinnon-small cell lung cancerNSCLCPGC-1α

Identifiers

PMID36430689
PMCPMC9694131
OpenAlexW4309605966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.